42 CFR 412.100
§ 412.100 Special treatment: Kidney transplant programs.
United States · 42 CFR — Public Health · Status: effective
Cite this
- Citation
- 42 CFR 412.100, § 412.100 Special treatment: Kidney transplant programs, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/203553
- Permanent ID
ys:prov:203553@1- SHA-256
f4bebd266d7a84d2e1c2426aa05e15d61884d603782d8375a8e2bbf8dddb473e
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Adjustments for kidney transplant programs.
(1) CMS adjusts the inpatient prospective payment system (IPPS) rates for inpatient operating costs determined under subparts D and E of this part for hospitals with approved kidney transplant programs (discussed at § 482.104 of this chapter) to remove the net costs associated with kidney acquisition.
(2)(i) Payment for Medicare kidney acquisition costs, as set forth in subpart L of part 413 of this chapter, is made on a reasonable cost basis apart from the prospective payment rate for inpatient operating costs.
(ii) IPPS payment to the hospital is adjusted in each cost reporting period to reflect an amount necessary to compensate the hospital for reasonable costs of Medicare kidney acquisition.
(b) Costs of kidney acquisition. Kidney acquisition costs include allowable costs incurred in the acquisition of a kidney from a living or a deceased donor by the hospital, or from a deceased donor by an organ procurement organization. These costs are listed in § 413.402(b) of this chapter.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.